Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,139,000 | 1,342,000 | 2,595,000 | 3,641,000 | 3,343,000 |
| Marketable Securities | 17,694,000 | 18,650,000 | 15,255,000 | 19,649,000 | 32,779,000 |
| Receivables | 8,025,000 | 8,221,000 | 8,225,000 | 8,176,000 | 8,401,000 |
| Inventories | 7,508,000 | 7,578,000 | 6,783,000 | 7,513,000 | 5,663,000 |
| Income taxes - deferred | 3,374,000 | N/A | N/A | N/A | 2,566,000 |
| Other current assets | 12,186,000 | 5,350,000 | 6,091,000 | 4,825,000 | 2,843,000 |
| TOTAL | $49,926,000 | $41,141,000 | $38,949,000 | $43,804,000 | $55,595,000 |
| Non-Current Assets | |||||
| PPE Net | 13,385,000 | 13,865,000 | 13,318,000 | 13,766,000 | 11,762,000 |
| Investments And Advances | 2,767,000 | 7,015,000 | 7,116,000 | 15,999,000 | 17,518,000 |
| Intangibles | 88,622,000 | 104,693,000 | 107,097,000 | 88,598,000 | 77,235,000 |
| Other Non-Current Assets | 4,723,000 | 5,082,000 | 5,135,000 | 5,214,000 | 5,457,000 |
| TOTAL | $109,497,000 | $130,655,000 | $132,666,000 | $123,577,000 | $111,972,000 |
| Total Assets | $159,422,000 | $171,797,000 | $171,615,000 | $167,381,000 | $167,566,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,831,000 | 9,953,000 | 10,688,000 | 10,159,000 | 5,141,000 |
| Accounts payable and accrued liabilities | 4,674,000 | 4,656,000 | 4,536,000 | 3,620,000 | 3,210,000 |
| Accrued Expenses | 2,397,000 | 2,196,000 | 2,487,000 | 2,359,000 | 1,841,000 |
| Other current liabilities | 12,643,000 | 11,115,000 | 11,023,000 | 10,990,000 | 9,153,000 |
| TOTAL | $31,858,000 | $30,427,000 | $31,115,000 | $29,399,000 | $21,587,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,909,000 | 33,538,000 | 31,398,000 | 28,740,000 | 31,541,000 |
| aiOther Non-Current Liabilities | 27,161,000 | 32,229,000 | 18,478,000 | 17,342,000 | 19,468,000 |
| TOTAL | $63,806,000 | $69,714,000 | $80,660,000 | $72,985,000 | $74,358,000 |
| Total Liabilities | $95,664,000 | $100,141,000 | $111,776,000 | $102,384,000 | $95,944,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,551,805 | 5,952,865 | 5,951,872 | 6,184,140 | 6,128,856 |
| Common Shares | 467,000 | 464,000 | 461,000 | 459,000 | 455,000 |
| Retained earnings | 89,554,000 | 85,291,000 | 71,774,000 | 71,993,000 | 72,176,000 |
| Other shareholders' equity | -10,906,000 | -8,952,000 | -10,716,000 | -9,218,000 | -6,965,000 |
| TOTAL | $63,758,000 | $71,656,000 | $59,840,000 | $64,998,000 | $71,622,000 |
| Total Liabilities And Equity | $159,422,000 | $171,797,000 | $171,616,000 | $167,382,000 | $167,566,000 |